The fresh capital injection will accelerate the commercial launch of Humors Tech’s flagship product, Respyr. The funds will also be used for clinical validation studies and expansion into global markets, underscoring the startup’s ambitious growth plans.
About Respyr
Founded by Ankur Jaiswal and Suchita Kanaldekar, Humors Tech aims to address a significant public health challenge through its innovative product, Respyr. This breath-based health screening device offers early detection and routine monitoring of critical lifestyle disorders such as diabetes, hypertension, and various heart, liver, kidney, and respiratory issues.
Respyr is designed to be accessible and user-friendly, integrating seamlessly with fitness apps and wearables. This integration allows users to track their health metrics more comprehensively and is an entry point to telemedicine platforms. Based on screening results, Respyr can route users for timely medical interventions, potentially preventing severe health outcomes.
Business Model and Market Reach
Humors Tech operates on a dual B2B and B2B2C model. This strategy enables the startup to cater to many clients, including corporates, insurers, government hospitals, remote healthcare facilities, and individual consumers. Respyr’s applications extend to employee health programs, insurance engagement, expedited medical screening, and improving healthcare access in rural areas.
With a focus on scalable impact, Humors Tech aims to tap into a total addressable market (TAM) of 612 million individuals in India. Initially, they target a serviceable available market (SAM) of 163 million health-conscious individuals, positioning themselves to make significant inroads in the health tech sector.
Future Outlook
The successful pre-seed round marks a pivotal moment for Humors Tech, positioning them to bring innovative health solutions to a broader audience. By leveraging the expertise and support from Venture Catalysts, Humors Tech is set to enhance public health outcomes on a large scale, potentially transforming the landscape of preventive healthcare.
